Episcleral eye plaque dosimetry comparison for the Eye Physics EP917 using Plaque Simulator and Monte Carlo simulation

Leonard W. Zimmermann, Ahmad Amoush, Douglas A. Wilkinson

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

This work is a comparative study of the dosimetry calculated by Plaque Simulator, a treatment planning system for eye plaque brachytherapy, to the dosimetry calculated using Monte Carlo simulation for an Eye Physics model EP917 eye plaque. Monte Carlo (MC) simulation using MCNPX 2.7 was used to calculate the central axis dose in water for an EP917 eye plaque fully loaded with 17 IsoAid Advantage (125)I seeds. In addition, the dosimetry parameters Λ, gL(r), and F(r,θ) were calculated for the IsoAid Advantage model IAI-125 (125)I seed and benchmarked against published data. Bebig Plaque Simulator (PS) v5.74 was used to calculate the central axis dose based on the AAPM Updated Task Group 43 (TG-43U1) dose formalism. The calculated central axis dose from MC and PS was then compared. When the MC dosimetry parameters for the IsoAid Advantage (125)I seed were compared with the consensus values, Λ agreed with the consensus value to within 2.3%. However, much larger differences were found between MC calculated gL(r) and F(r,θ) and the consensus values. The differences between MC-calculated dosimetry parameters are much smaller when compared with recently published data. The differences between the calculated central axis absolute dose from MC and PS ranged from 5% to 10% for distances between 1 and 12 mm from the outer scleral surface. When the dosimetry parameters for the (125)I seed from this study were used in PS, the calculated absolute central axis dose differences were reduced by 2.3% from depths of 4 to 12 mm from the outer scleral surface. We conclude that PS adequately models the central dose profile of this plaque using its defaults for the IsoAid model IAI-125 at distances of 1 to 7 mm from the outer scleral surface. However, improved dose accuracy can be obtained by using updated dosimetry parameters for the IsoAid model IAI-125 (125)I seed.

Original languageEnglish (US)
Pages (from-to)5659
Number of pages1
JournalJournal of Applied Clinical Medical Physics
Volume16
Issue number6
DOIs
StatePublished - 2015

Fingerprint

Physics
simulators
Dosimetry
dosimeters
Seeds
Simulators
dosage
physics
Seed
seeds
simulation
Brachytherapy
Monte Carlo simulation
Water
planning
formalism
Planning
profiles
water

Keywords

  • I
  • Dosimetry
  • Eye plaque brachytherapy
  • Monte Carlo

ASJC Scopus subject areas

  • Radiation
  • Instrumentation
  • Radiology Nuclear Medicine and imaging

Cite this

Episcleral eye plaque dosimetry comparison for the Eye Physics EP917 using Plaque Simulator and Monte Carlo simulation. / Zimmermann, Leonard W.; Amoush, Ahmad; Wilkinson, Douglas A.

In: Journal of Applied Clinical Medical Physics, Vol. 16, No. 6, 2015, p. 5659.

Research output: Contribution to journalArticle

@article{2c6634013865482a925ee3a3923e324a,
title = "Episcleral eye plaque dosimetry comparison for the Eye Physics EP917 using Plaque Simulator and Monte Carlo simulation",
abstract = "This work is a comparative study of the dosimetry calculated by Plaque Simulator, a treatment planning system for eye plaque brachytherapy, to the dosimetry calculated using Monte Carlo simulation for an Eye Physics model EP917 eye plaque. Monte Carlo (MC) simulation using MCNPX 2.7 was used to calculate the central axis dose in water for an EP917 eye plaque fully loaded with 17 IsoAid Advantage (125)I seeds. In addition, the dosimetry parameters Λ, gL(r), and F(r,θ) were calculated for the IsoAid Advantage model IAI-125 (125)I seed and benchmarked against published data. Bebig Plaque Simulator (PS) v5.74 was used to calculate the central axis dose based on the AAPM Updated Task Group 43 (TG-43U1) dose formalism. The calculated central axis dose from MC and PS was then compared. When the MC dosimetry parameters for the IsoAid Advantage (125)I seed were compared with the consensus values, Λ agreed with the consensus value to within 2.3{\%}. However, much larger differences were found between MC calculated gL(r) and F(r,θ) and the consensus values. The differences between MC-calculated dosimetry parameters are much smaller when compared with recently published data. The differences between the calculated central axis absolute dose from MC and PS ranged from 5{\%} to 10{\%} for distances between 1 and 12 mm from the outer scleral surface. When the dosimetry parameters for the (125)I seed from this study were used in PS, the calculated absolute central axis dose differences were reduced by 2.3{\%} from depths of 4 to 12 mm from the outer scleral surface. We conclude that PS adequately models the central dose profile of this plaque using its defaults for the IsoAid model IAI-125 at distances of 1 to 7 mm from the outer scleral surface. However, improved dose accuracy can be obtained by using updated dosimetry parameters for the IsoAid model IAI-125 (125)I seed.",
keywords = "I, Dosimetry, Eye plaque brachytherapy, Monte Carlo",
author = "Zimmermann, {Leonard W.} and Ahmad Amoush and Wilkinson, {Douglas A.}",
year = "2015",
doi = "10.1120/jacmp.v16i6.5659",
language = "English (US)",
volume = "16",
pages = "5659",
journal = "Journal of applied clinical medical physics / American College of Medical Physics",
issn = "1526-9914",
publisher = "American Institute of Physics Publising LLC",
number = "6",

}

TY - JOUR

T1 - Episcleral eye plaque dosimetry comparison for the Eye Physics EP917 using Plaque Simulator and Monte Carlo simulation

AU - Zimmermann, Leonard W.

AU - Amoush, Ahmad

AU - Wilkinson, Douglas A.

PY - 2015

Y1 - 2015

N2 - This work is a comparative study of the dosimetry calculated by Plaque Simulator, a treatment planning system for eye plaque brachytherapy, to the dosimetry calculated using Monte Carlo simulation for an Eye Physics model EP917 eye plaque. Monte Carlo (MC) simulation using MCNPX 2.7 was used to calculate the central axis dose in water for an EP917 eye plaque fully loaded with 17 IsoAid Advantage (125)I seeds. In addition, the dosimetry parameters Λ, gL(r), and F(r,θ) were calculated for the IsoAid Advantage model IAI-125 (125)I seed and benchmarked against published data. Bebig Plaque Simulator (PS) v5.74 was used to calculate the central axis dose based on the AAPM Updated Task Group 43 (TG-43U1) dose formalism. The calculated central axis dose from MC and PS was then compared. When the MC dosimetry parameters for the IsoAid Advantage (125)I seed were compared with the consensus values, Λ agreed with the consensus value to within 2.3%. However, much larger differences were found between MC calculated gL(r) and F(r,θ) and the consensus values. The differences between MC-calculated dosimetry parameters are much smaller when compared with recently published data. The differences between the calculated central axis absolute dose from MC and PS ranged from 5% to 10% for distances between 1 and 12 mm from the outer scleral surface. When the dosimetry parameters for the (125)I seed from this study were used in PS, the calculated absolute central axis dose differences were reduced by 2.3% from depths of 4 to 12 mm from the outer scleral surface. We conclude that PS adequately models the central dose profile of this plaque using its defaults for the IsoAid model IAI-125 at distances of 1 to 7 mm from the outer scleral surface. However, improved dose accuracy can be obtained by using updated dosimetry parameters for the IsoAid model IAI-125 (125)I seed.

AB - This work is a comparative study of the dosimetry calculated by Plaque Simulator, a treatment planning system for eye plaque brachytherapy, to the dosimetry calculated using Monte Carlo simulation for an Eye Physics model EP917 eye plaque. Monte Carlo (MC) simulation using MCNPX 2.7 was used to calculate the central axis dose in water for an EP917 eye plaque fully loaded with 17 IsoAid Advantage (125)I seeds. In addition, the dosimetry parameters Λ, gL(r), and F(r,θ) were calculated for the IsoAid Advantage model IAI-125 (125)I seed and benchmarked against published data. Bebig Plaque Simulator (PS) v5.74 was used to calculate the central axis dose based on the AAPM Updated Task Group 43 (TG-43U1) dose formalism. The calculated central axis dose from MC and PS was then compared. When the MC dosimetry parameters for the IsoAid Advantage (125)I seed were compared with the consensus values, Λ agreed with the consensus value to within 2.3%. However, much larger differences were found between MC calculated gL(r) and F(r,θ) and the consensus values. The differences between MC-calculated dosimetry parameters are much smaller when compared with recently published data. The differences between the calculated central axis absolute dose from MC and PS ranged from 5% to 10% for distances between 1 and 12 mm from the outer scleral surface. When the dosimetry parameters for the (125)I seed from this study were used in PS, the calculated absolute central axis dose differences were reduced by 2.3% from depths of 4 to 12 mm from the outer scleral surface. We conclude that PS adequately models the central dose profile of this plaque using its defaults for the IsoAid model IAI-125 at distances of 1 to 7 mm from the outer scleral surface. However, improved dose accuracy can be obtained by using updated dosimetry parameters for the IsoAid model IAI-125 (125)I seed.

KW - I

KW - Dosimetry

KW - Eye plaque brachytherapy

KW - Monte Carlo

UR - http://www.scopus.com/inward/record.url?scp=84989187836&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84989187836&partnerID=8YFLogxK

U2 - 10.1120/jacmp.v16i6.5659

DO - 10.1120/jacmp.v16i6.5659

M3 - Article

C2 - 26699577

AN - SCOPUS:84949675223

VL - 16

SP - 5659

JO - Journal of applied clinical medical physics / American College of Medical Physics

JF - Journal of applied clinical medical physics / American College of Medical Physics

SN - 1526-9914

IS - 6

ER -